Streetbeat News

Regulatory

BABA

Alibaba Group Holding Ltd (NYSE:BABA) shares are trading lower due to the ongoing crisis with China Evergrande Group. The crisis has raised concerns about economic stability in China, which could impact Alibaba's revenue growth and lead to tighter regulatory oversight. Alibaba has already been under increased regulatory scrutiny in China.

Portfolio Pulse from Henry Khederian

September 28, 2023 | 3:04 pm

MSOS

The 'Booze and Bud: Friend or Foe?' event is starting at the Benzinga Capital Cannabis Conference. The event can be watched in real-time by Benzinga members. The article hints that MSOS may be mentioned during the event.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:53 pm

FOLD

Amicus Therapeutics (NASDAQ:FOLD) has received FDA approval for its two-component therapy, Pombiliti and Opfolda, for adults with late-onset Pompe disease. The approval is based on data from the Phase 3 PROPEL study. The company plans to immediately launch the treatment in the U.S. The therapy has also been approved in the European Union and the United Kingdom.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:43 pm

HE

The CEO of Hawaiian Electric (HE) has acknowledged being aware of a red flag warning for high winds forecast. The impact of this on the company's operations and infrastructure is not detailed in the news.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:42 pm

MSOS

SPY

Norman Birenbaum of the FDA has announced that the agency has completed its evaluation of marijuana, as per the President's directive. However, the details of the evaluation or recommendation have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:35 pm

HE

The CEO of Hawaiian Electric (HE) has stated that the company is working to understand the recent incident and is fully cooperating with federal and state investigators. This statement was made during a testimony before a U.S. House Committee.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:34 pm

MSOS

Norman Birenbaum of the FDA has stated that there is currently no regulator in place for the cannabis industry, presenting an opportunity. The statement was made during a Benzinga Cannabis Capital Conference.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:34 pm

MSOS

Patrick Cournoyer from the FDA has suggested that a pathway that's fit for purpose could allow for the right type of rules that could draw the line better and keep up to date with never-ending innovation. The news was shared during a Benzinga conference.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:31 pm

HE

The CEO of Hawaiian Electric (HE) testified before a U.S. House Committee, expressing the company's desire to learn from the events of August 8 to prevent a recurrence.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:30 pm

MSOS

Patrick Cournoyer from the FDA has stated that the agency is communicating within its own authorities, issuing public health alerts and compliance-related work. They have also issued warning letters. The news was shared during a Benzinga Cannabis Capital Conference.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:29 pm